Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Greene

Showing results (981-990 of 1,154) with videos related to

Pageof 116
Sort By:
Annals of Internal Medicine|November 1, 1986
Assessing clinical skills of residents with standardized patientsP L Stillman, D B Swanson, S Smee, et al.
Open Heart|June 11, 2020
Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillationRowlens M Melduni, Waldemar E Wysokinski, Zhenzhen Wang, et al.
Cancers|October 14, 2023
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of MetastasesBaylee A Porter, Candace Frerich, Muriel Lainé, et al.
Drug and Alcohol Review|January 20, 2025
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systemsKatherine Z Isoardi, Sam Alfred, Courtney Weber, et al.
Schizophrenia Bulletin|December 28, 2020
A Role for Somatostatin-Positive Interneurons in Neuro-Oscillatory and Information Processing Deficits in SchizophreniaAlice B Van Derveer, Georgia Bastos, Antanovia D Ferrell, et al.
Breast Cancer Research and Treatment|January 1, 1993
The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domainS A Fuqua, D C Allred, R M Elledge, et al.
Nature Structural Biology|April 16, 2002
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonismAndrew K Shiau, Danielle Barstad, James T Radek, et al.
Cancer Research|January 15, 1992
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumorsS A Fuqua, S D Fitzgerald, D C Allred, et al.
Oncology|June 7, 2014
Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignanciesSuzanne R Hayman, Juan C Calle, Aminah Jatoi, et al.
The New England Journal of Medicine|March 21, 1991
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression TrialD S Echt, P R Liebson, L B Mitchell, et al.
Pageof 116

Showing results (981-990 of 1,154) with videos related to

Sort By:
Pageof 116
Annals of Internal Medicine|November 1, 1986
Assessing clinical skills of residents with standardized patientsP L Stillman, D B Swanson, S Smee, et al.
Open Heart|June 11, 2020
Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillationRowlens M Melduni, Waldemar E Wysokinski, Zhenzhen Wang, et al.
Cancers|October 14, 2023
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of MetastasesBaylee A Porter, Candace Frerich, Muriel Lainé, et al.
Drug and Alcohol Review|January 20, 2025
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systemsKatherine Z Isoardi, Sam Alfred, Courtney Weber, et al.
Schizophrenia Bulletin|December 28, 2020
A Role for Somatostatin-Positive Interneurons in Neuro-Oscillatory and Information Processing Deficits in SchizophreniaAlice B Van Derveer, Georgia Bastos, Antanovia D Ferrell, et al.
Breast Cancer Research and Treatment|January 1, 1993
The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domainS A Fuqua, D C Allred, R M Elledge, et al.
Nature Structural Biology|April 16, 2002
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonismAndrew K Shiau, Danielle Barstad, James T Radek, et al.
Cancer Research|January 15, 1992
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumorsS A Fuqua, S D Fitzgerald, D C Allred, et al.
Oncology|June 7, 2014
Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignanciesSuzanne R Hayman, Juan C Calle, Aminah Jatoi, et al.
The New England Journal of Medicine|March 21, 1991
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression TrialD S Echt, P R Liebson, L B Mitchell, et al.
Pageof 116